Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Okyo Pharma Reports Safety And Efficacy Results In Its Phase 2 Trial Of OK-101 Ophthalmic Solution For Dry Eye Disease; The Company Says The Trial Achieved Statistical Significance For Both Sign And Symptom Endpoints

Author: Benzinga Newsdesk | January 08, 2024 08:43am

Posted In: OKYO